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Abstract
Background—There is little research documenting the post-treatment experiences and needs of 
oral/oropharyngeal cancer survivors.
Methods—In this cross-sectional study, 92 patients diagnosed with oral/oropharyngeal cancer 
diagnosed between 2 and 5 years prior completed a survey about oral cancer information and 
support needs.
Results—About half retrospectively reported that they did not receive a written treatment 
summary. The desire for more oral cancer information was common: One-third or more desired 
more information about long-term effects, recommended follow-up, and symptoms that should 
prompt contacting a doctor. Support needs were less common: Only a lack of energy was rated as 
a significant support need. Patients who had a recurrence, did not drink alcohol, and had a greater 
recurrence fear desired more information. Smokers and more distressed patients reported more 
support needs.
Conclusions—Survivors reported the desire for more oral cancer information. A desire for 
assistance was less common.
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Introduction
An estimated 45,780 new cases of oral and oropharyngeal cancer and 8,650 deaths are 
expected in the United States in 2015.1 Less than one-third (31%) of cases are diagnosed at a 
local stage, for which 5-year survival is 83%.2 Treatment entails single modality treatment 
of surgery or radiation, or a combination of surgery, radiation, and chemotherapy, depending 
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on the disease site. Because of the location of the structures, the disease and its treatment, 
this disease can cause debilitating and permanent disability. Surgery and radiation can cause 
a visible disfigurement in facial and neckline appearance and affect vital life functions such 
as the ability to swallow, taste, speak, and eat.3-6
The extensive rehabilitation and long-term maintenance needs of this population are 
complex and involve a diverse set of health care providers including head and neck surgeons, 
radiation oncologists, medical oncologists, plastic and reconstructive surgeons, nurses, 
dentists and prosthodontists, physical rehabilitation specialists, speech and swallowing 
experts, nutritionists, pathologists, and adjunctive services such as addiction services and 
psychiatry.7-9 Collaboration between the patient and the many providers is key to restoration 
of swallowing, taste, and speech, and the prevention of further deterioration of physical 
function. Survivors are expected to understand medical information, adhere to a complicated 
follow-up care regimen, and coordinate care with providers, and manage comorbid medical 
conditions. These patients are also at a high risk for disease recurrence. Approximately 20% 
of patients suffer a recurrence or diagnosis of metastatic disease within the first two years,10 
and thus the follow-up regimen includes regular surveillance. Follow-up care 
recommendations include an examination every 1 to 3 months in year 1, every 2 to 4 months 
in year 2, every 4 to 6 months in year 3, and every 6 to 12 months after five years.8 Post-
treatment baseline imaging of the primary affected area is recommended within three to six 
months of treatment, as are dental exams, and alcohol and smoking cessation counseling, if 
indicated.8 Because these patients rarely completely recover function, the complex medical 
needs persist throughout the remainder of the patient's lifetime, and require the commitment 
of the patient, family, and his/her many health care providers. The limited studies evaluating 
patient adherence with this demanding post-treatment regimen suggest that adherence may 
be a challenge, with between 30% and 50% of patients not adhering to recommended 
follow-up appointments.11-12
There have been many studies evaluating quality of life in oral/oropharyngeal cancer 
patients. Studies suggest that patients diagnosed with these cancers have a compromised 
quality of life compared to the general population (e.g,13). Long–term follow up studies 
suggest these patients continue to score worse on measures of role function (e.g.,14) and 
significantly worse than age-matched individuals on disease-specific problems such as 
swallowing, local pain, and dry mouth 3 years after diagnosis (e.g.,14) Patients express 
concerns about appearance, sense of taste, sense of smell, drooling, taking a long time to eat, 
speech problems, ability to work, intimacy, finances, body image worries, and 
embarrassment in social settings (e.g.,15). Adding to this complex picture is the fact that the 
oral cancer patient population has historically been older, male, and have multiple co-
morbidities associated with long-term substance use.16
Due to these issues, negotiating the transition back to “normal” life can be complex and 
difficult. Oeffinger and McCabe17 have delineated current practice and proposed general 
models of survivorship care. At the end of cancer treatment, the “usual practice” is that most 
cancer survivors are followed by their oncologists, whose focus is on monitoring persistent 
treatment toxicity and cancer recurrence.17 Planned or formal transition of the survivor from 
the oncologist to a primary care physician is infrequent.17,18 Patients may have difficulty 
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with the transition from being “on treatment” to optimum survivor follow-up care.19 Across 
cancers, this transition can result in unmet information and support needs. Indeed, research 
suggests that newly diagnosed oral cancer patients may have a number of unmet information 
needs.20 Unfortunately, there is little research documenting the unmet information and 
support needs of oral cancer survivors, both in terms of information and other supportive 
care needs and post-treatment care experiences. Oskam and colleagues21 studied oral cancer 
survivors’ rehabilitation needs over an 8 to 11 year time period after treatment ended and 
found that rehabilitation needs decreased after treatment ended, but that quality of life 
declined significantly. The most frequently-reported medical and rehabilitation needs were 
dental care and physical therapy.
Unlike oral and oropharyngeal cancers, there is a relatively extensive literature examining 
unmet needs among survivors of breast, colorectal, gynecological, lung, melanoma, prostate, 
and childhood cancers (see Harrison et al22 for a review of this topic). These studies have 
indicated that survivors commonly have medical care needs including: a desire to know what 
late effects to expect and what the recommended follow-up tests are, a desire for more 
guidance about diet, a desire to feel that they are managing their cancer with the help of the 
medical team, and a desire to know that health care services are available when 
required.23-25 Commonly-reported psychological concerns among survivors include sadness, 
anxiety, worry about cancer recurrence, spiritual needs (e.g., trying mind/body therapies), 
help reducing stress, help coping with others’ responses, concerns about the well-being of 
close family members, and sexual concerns.26-30 Commonly-reported physical concerns are 
pain, lack of energy, not being able to do the things he/she used to do, and being able to 
work around one's home.29,31,32 Less is known about post-treatment care experiences and 
correlates of information and support needs, although several studies of survivors with other 
types of cancer have suggested that higher levels of support needs are associated with less 
education,23 marital status (mixed results),33-35 time since diagnosis (mixed results),23,29 not 
being in remission,36 age (mixed results),30,37 more comorbid medical conditions,38 more 
physical symptoms,29,30,39,40 higher psychological distress,23,25,26,40,41 a lower quality of 
life,23,42 and more fear of recurrence.38
This cross-sectional study had two aims. The first aim was to describe the post-treatment 
care experiences, informational needs, and support needs of oral and oropharyngeal cancer 
survivors Treatment care experiences (e.g., receipt of a treatment summary) were described 
retrospectively. The second aim was to examine background (e.g. age, education, gender, 
current smoking), medical, and psychosocial correlates of informational and support needs 
among oral and oropharyngeal cancer survivors. With regard to background factors, we 
proposed that older and less educated survivors would report more unmet informational and 
support needs. We proposed that survivors who experienced a cancer recurrence and had 
more oral-cancer physical symptoms (e.g., trouble swallowing) would report more 
information and support needs. With regard to psychological factors, we hypothesized that 
greater informational and support needs would be associated with higher levels of fear of 
cancer recurrence, a greater negative impact of oral cancer on different aspects of their lives 
and activities (e.g., social life, appearance), and psychological distress, independent of 
background and medical factors. The sample consisted of relatively recent survivors 
(between 2 and 5 years since diagnosis) who were sampled from a state cancer registry.
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Patients were eligible for this study if they were diagnosed with oral or oropharyngeal 
cancer in 2011 and currently free of cancer. Participants completed a written survey that took 
an average of 59 minutes to complete (range = 20 minutes to 5 hours). Prior to initiation, the 
Institutional Review Board of the Rutgers Robert Wood Johnson Medical School approved 
this study, and written informed consent was received from all participants. All procedures 
performed in studies involving human participants were in accordance with the ethical 
standards of the institutional and/or national research committee and with the 1964 Helsinki 
declaration and its later amendments or comparable ethical standards.
Participants were recruited from the New Jersey State Cancer Registry (NJSCR). The 
NJSCR confirmed the patient's eligibility and contacted the patients’ physician to ensure that 
there were no contraindications for participation (e.g., patient deceased, mentally incapable 
of consenting or completing a written survey). After physician contact, patients were sent an 
introductory packet by the NJSCR. The NJSCR packet contained an informed consent, 
survey, a stamped envelope, and a letter asking interested participants to complete the survey 
and return it. For a small subset of patients, the NJSCR packet contained only a written 
consent form permitting the Rutgers Cancer Institute of New Jersey (RCINJ) staff to contact 
them regarding the study. In this scenario, participants who returned the consent were then 
contacted by the RCINJ staff, and, if interested, an informed consent, survey, and stamped 
envelope was provided. Study staff contacted participants weekly by telephone if they did 
not return the survey. Patients were considered passive refusers as they did not return a 
survey after repeated call attempts during daytime hours, nights, and weekends over a three 
week period after the letter (or survey) was sent.
Of the 214 patients approached, 17 were not eligible (for various reasons), 105 refused, and 
92 patients completed an informed consent and survey. The acceptance rate among eligible 
patients was 46.2%. Most participants were passive refusers (i.e., they did not respond to 
contacts and did not send in a survey). Comparisons between refusers and participants on the 
available background (age category, gender, white vs non-white race) and medical (cancer 
site, stage) information indicated there were no significant differences between participants 
and refusers.
Measures
Background information—The survey contained information about age, marital status, 
gender, education, ethnicity/race, health insurance coverage, and income.
Substance use—Current substance use measured alcohol consumption by assessing how 
many days a week or month the person had at least one drink of alcohol (days per week, 
days in past 30 days, or no drinks in past 30 days) as well as cigarette smoking use (every 
day, some days, not at all). For the current study, a dichotomous variable was used (yes/ no) 
to indicate current smoking status and current use of alcohol (any).
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Medical information—Date of diagnosis, type of cancer, cancer stage, recurrence history, 
treatment history (surgery, chemotherapy, radiation), and a confirmation that the patient was 
currently free of disease were collected from patients. Diagnosis date was confirmed by the 
NJSCR. The type and stage of disease were provided by the NJSCR, along with the hospital 
where the patient was treated. The 35-item EORTC QLQ H&N3543 was used to assess 
common side effects of oral cancer and its treatment including swallowing, dry mouth, taste, 
smell, social eating, and pain. Items were rated from 1 = not at all, to 4 = very much. For 
purposes of this study, an average of the 35 items was used. Higher scores indicate more 
symptoms. Internal consistency, as measured by Cronbach's alpha, was .96.
Follow-up care experiences—Survey items from the National Cancer Institute Follow-
up Care Use Among Survivors (FOCUS) survey were used to assess the follow-up care 
experiences.44 The FOCUS has been used in prior research.45,46 Follow-up care history 
assessed: whether the patient saw a physician for follow-up care in the past two years, the 
reasons for those appointments, and where the care was received (general medicine clinic, 
specialty clinic). Several questions assessed what follow-up information was provided: “Has 
a doctor or health care professional ever discussed with you what late or long term side 
effects of cancer treatment you may experience over time?” (No, Yes, Discussed somewhat, 
Yes, Discussed in detail) and, “At the completion of treatment, did you receive a written 
summary from your doctor that mentioned details of the treatment you had received and 
provided other important details regarding your cancer care?” (No, Yes, Not sure). Follow-
up treatment experiences were also assessed, which included what treatment care was 
received, participants’ satisfaction with care, who the primary cancer care was obtained 
from, participants’ preferences for who should provide follow-up cancer care, and 
participants’ views of ideal follow-up care.
Impact of cancer—A 17-item instrument was developed for this study to assess the 
positive and negative impact of oral cancer on participants’ lives. Items included, “Your 
work life or career,” “Your body image and confidence in your appearance,” “Your 
participation in social activities,” “Your exercise activities,” and “Your ability to enjoy life”. 
Response choices were: 0 = “does not apply,” 1= “very negative impact”, 2 = “somewhat 
negative impact”, 3 = “no impact,” to 5 = “very positive impact.” Participants were asked to 
consider the time since they were first diagnosed with oral cancer to the present when 
providing ratings. Higher scores indicate a more positive impact of cancer. Internal 
consistency, as calculated by Cronbach's alpha, was .91.
Fear of recurrence—The first four items of the Concerns about Recurrence Scale were 
adapted for this study.47 These items assess global fears about disease recurrence and assess 
the amount of time spent thinking about recurrence, how upsetting the possibility of a 
recurrence is, how often the person worries about recurrence, and fear of recurrence. Items 
were rated on a 6-point Likert scale (e.g., 1= I don't think about it at all, to 6 = I think about 
it all the time). An average item score was used in the analysis, with higher scores indicating 
greater fear of recurrence. Internal consistency, as calculated by Cronbach's alpha, was .94.
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Cancer–Specific Distress—The Impact of Events Scale-Revised48 is a 22-item scale 
that assesses cancer-related distress. The scale has intrusive symptoms (dreams), avoidant 
symptoms (try not to think about it), and hyper-arousal symptoms (e.g., felt watchful or on-
guard). Items were rated on a five point scale (0 = Not at all, 1 = a little, 3 = quite a bit, and 
5 = extremely). Participants rated their responses to their oral cancer diagnosis and 
treatment. Feelings within the past week were assessed. A total score was used in the 
analysis. Internal consistency, as calculated by Cronbach's alpha, was .97.
Oral Cancer-Related Information Needs—An 11-item scale was adapted from the 
Information about Health Related Topics section of the FOCUS survey.44 Four items from 
the FOCUS survey included: information about health related topics, managing anxiety 
about recurrence, and late and long terms side effects from oral cancer treatment. The 
remaining 7 items were composed for this study which contained health-related topics about 
which oral cancer survivors might need more information. Items were created based on a 
review of the literature on the side effects of oral cancer and included desiring more 
information about what follow-up tests were needed, what symptoms should prompt a call to 
a doctor, what late and long-term side effects to expect, and how to manage anxiety and 
maintain good oral health. Participants were asked whether they would like more 
information about each topic “at this time”. Responses were rated yes or no. A total score 
was used in the analysis. Internal consistency, as calculated by Cronbach's alpha, was .90. 
Items are shown in Table 2.
Support Needs—An shortened version of the Supportive Care Needs Survey36 was used. 
This 25-item survey assessed needs across five domains: physical, psychological, health care 
systems and information, patient care and support, and sexuality domains. Nine items were 
excluded from the original Supportive Care Needs Survey to shorten the instrument. Items 
were selected to minimize overlap with other items on the scale (i.e., “feelings of sadness” 
was deleted due to the overlap with “feeling down or depressed”; “changes in sexual 
feelings” was deleted due to overlap with “changes in your sexual relationship”).. . 
Participants were asked to indicate the extent to which they needed help (1 = Did not need 
help, 5 = High need) in the past month. The measure has four domains: Physical/daily living, 
psychological, patient care and support, sexuality, and health system and information needs. 
Support needs in each domain were averaged and a total score was calculated across 
domains. Internal consistency for the total score, as calculated by Cronbach's alpha on the 
entire scale was .97.
Statistical analysis plan: Data were analyzed utilizing Statistical Packages for Social 
Sciences (SPSS). To address the first aim, we calculated descriptive statistics for the on the 
post-treatment care experiences were reported, and oral cancer-related informational and 
support needs. To address the second aim, analyses were conducted in two steps. In the first 
step, correlations (for continuous variables) or t-tests (for dichotomous variables) were 
calculated for the demographic, medical, and psychological variables included in the 
predictive model. The demographic variables included age, gender (dichotomous), ethnicity 
(white or not white; dichotomous), marital status (married vs. not, dichotomous), household 
income, education, smoking status (dichotomous), and current alcohol intake (dichotomous). 
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Medical variables included stage of disease, whether the cancer recurred or not 
(dichotomous), time since original diagnosis, and the number of oral cancer symptoms. 
Psychological variables included impact of cancer, fear of recurrence, and cancer-related 
distress. In the second step, a stepwise regression was conducted entering significant 
correlates from each category, in three steps. That is, the background, medical, and 
psychosocial variables were entered in three separate steps. The dependent variable, support 
needs, was comprised of an average item score across all of the domains assessed, and the 
information needs scale was an average across all items, as well. Note that the analyses of 
support needs in the separate domains were the same as those for the total score. For 
simplicity, only the total score results are presented for the support needs scale.
Results
Descriptive information on the sample
Descriptive information about the sample is in Table 1. The majority of participants were 
white (88%), more than two thirds were male, the average age was 62 years, and more than 
half of the sample completed some college or a lower level of education. Two-thirds of the 
sample was married, and the vast majority of participants carried medical insurance (98%). 
A third of the sample worked full-time and a third were retired. About 15% of participants 
were current smokers and about 60% currently drank alcohol.
The most common tumor sites were the base of the tongue (47%) and tonsils (31.5%). Over 
half were diagnosed with stage 4 disease (53.3%), and a portion of the sample (7.6%) 
experienced a recurrence of the cancer since the original diagnosis. Average time since the 
original diagnosis was approximately three years (range = 2 years to 5 years). All 
participants with the exception of one had completed medical treatment. The most common 
treatments given at the time of the original diagnosis and recurrence were surgery, radiation 
and chemotherapy combined (33.6%), followed by radiation and chemotherapy combined 
(31.4%). The most commonly-experienced oral cancer side effects were dry mouth, sticky 
saliva, and dental problems (see Table 5). There was missing data on hospital site the 
participant was treated at for 38% of the sample. Among the participants for whom 
treatment site information was in the SEER records, participants received treatment or 
evaluation at 35 different hospitals. Thirty-five percent received treatment/assessment at a 
comprehensive cancer center.
Comparisons were made with the SEER statistics for the United States for cases diagnosed 
in 2007 to 20122. The ethnicity, gender, and stage composition of the sample was very 
similar to the population of persons diagnosed with oral and oropharyngeal cancers. 
However, the present sample was comprised of a higher percentage of patients with tongue 
cancer (30%) and tonsil cancer (18%) and a lower percentage of oropharyngeal cancers 
(18%) than the US population.
Post-treatment Care Experiences
Table 2 provides a summary of the key post-treatment care experiences. Most participants 
reported that they were informed by their treating physician that there was a need for follow-
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up medical care after treatment ended. Of the participants who reported that they were 
informed of the need for follow-up care, the primary reason they were told they needed this 
care was to check for signs of disease recurrence. Participants also reported that checking for 
signs of disease recurrence as the most important reason for obtaining follow-up care. The 
vast majority of participants reported that they had been seen by a cancer specialist for 
follow-up care since their original oral cancer diagnosis. Additional health care providers 
that participants reported they received follow-up care from were: a dentist a primary care 
physician, an ear, nose, and throat specialist a speech pathologist a cardiologist (8.7%), and a 
physical therapist.
Most participants considered the cancer specialist as their primary health care provider for 
cancer-related follow-up care. The most commonly-nominated provider identified among 
those not nominating the oncologist were an ear, nose, and throat specialist and a primary 
care physician. About half of participants reported that a health care professional had 
discussed in detail the possible late or long-term side effects of oral cancer treatment they 
might experience over time, 29.7% of patients reported that a health care provider discussed 
possible effects in a somewhat detailed manner, and 22% reported possible late and long-
term side effects were not discussed with any health care professional. Satisfaction with 
follow-up cancer care was extremely high, with 89.8% of participants reporting the quality 
was very good or excellent.
In terms of post-treatment care plans, approximately half of the participants reported that 
they did not receive a written summary of the cancer treatments they received and details 
about recommended post-treatment cancer care. More than half of the sample reported they 
would have liked to have a summary provided.
Oral Cancer-related Information and support needs
Oral cancer-related information needs are summarized in Table 3. The most commonly-
reported topics that patients desired more information about regarded the late and long-term 
side effects to expect, recommended oral cancer-related follow-up tests, suspicious 
symptoms that should prompt contacting a doctor, and how to maintain good oral health. 
Managing changes in marital or dating life and dealing with social life problems were the 
least-endorsed information needs, with 21% or fewer participants stating that they desired 
more information about marital/dating or social life.
Support needs are summarized in Table 4. Support needs that were rated “moderate” or 
“high” need for help were in the pain and daily living and health system domains: lack of 
energy (25%), being informed of test results in a timely manner (24.2%), being adequately 
informed about the benefits and side effects of treatments before choosing them (23.4%), 
and having a health care provider to talk to about his/her condition, treatment, and follow-up 
(24.2%). In contrast, support needs that were reported as issues the participant did not need 
help with in the past month by the majority of the sample were: having more choice about 
which cancer specialist the patient sees (90%), feelings about death and dying (82.6%), and 
being treated in a clinic that was as physically pleasant as possible (81%).
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Concerns about recurrence, cancer-specific distress, and impact of cancer
Descriptive information is in Table 5. Concerns about cancer recurrence were relatively low 
(M = 2.5, SD = 1.4, 6 is the highest rating). Single item means ranged between 2.3 to 2.7. 
An examination of frequency ratings indicated that approximately 9% of participants 
reported a great deal of time spent worrying about recurrence (e.g., a rating of 5 or 6, 6= “I 
think about it all the time”). The most highly-rated item was the degree of upset when 
considering the possibility of recurrence, with approximately 20% of participants reporting 
that it would make them very or extremely upset (rating of 5 or 6; 6 = It makes me extremely 
upset). In terms of cancer–specific distress (M = 12.5, SD = 18.0), there are limited data on 
mixed gender populations of cancer survivors (two to five years post-treatment) using the 
IES-R. The IES-R item mean of .57 (SD = .82) is significantly lower than means reported in 
a study of mixed gender rectal cancer survivors (M = 1.22; SD = .40; t (168) = 7.2, p < .
05).49
The overall impact of oral cancer of life domains was somewhat negative, with the mean 
score for the scale of 2.1 (2 = Somewhat negative impact) (SD = .89). The areas of life most 
negatively impacted were patients’ diet–what the patient can and cannot eat (49.5%), 
finances (38%), body image and confidence in one's appearance (36%), exercise activities 
(33%), and the ability to enjoy life (31%).
Predictors of Information and Support Needs
Bivariate associations between background variables and total information needs suggested 
that age, gender, marital status, education level, income, health insurance status, and current 
smoking status were not significantly associated with information needs. However, non-
white participants (t (88) = 3.1, p < .01) and participants who did not currently drink alcohol 
(t (88) = 3.0, p = .004) reported significantly more total information needs. Associations 
between medical variables and information needs indicated that participants who were 
diagnosed with later stage disease (F (4,82) = 4.5, p < .01), participants who had 
experienced a cancer recurrence (t (88) = 3.4, p = .001), and participants who reported a 
greater number of oral cancer symptoms (r = .46, p < .001) reported significantly higher 
information needs. Time since diagnosis was not significantly associated with information 
needs. Associations between psychosocial variables with information needs suggested that 
greater cancer-specific distress (r = .47, p < .001) and higher fears of recurrence (r = .51, p 
< .001) were significantly associated with greater information needs, but impact of cancer 
was not significantly associated with information needs. The final regression predicting 
information needs included ethnicity (white/non-white) and alcohol use in the first step, 
stage (1 to 3 vs 4), cancer recurrence, and oral cancer symptoms in the second step, followed 
by cancer-specific distress and fear of recurrence in the third step. Results are shown in the 
top panel of Table 6. Higher informational needs were significantly associated with not 
drinking alcohol, having a recurrence, and higher fear of recurrence. The group of variables 
accounted for 45.3% of the variance in information needs.
Associations between background variables and support needs suggested that age, gender, 
education level, marital status (married or not), ethnicity, health insurance status, and current 
alcohol use were not significantly associated with total support needs. However, participants 
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with a lower income (r =−.23, p < .05) and who currently smoked (t (89) = −5.4, p < .01) 
reported significantly more support needs. Associations between medical variables and 
support needs indicated that participants who were survivors for a longer time period (r = .
22, p < .05) and had a greater number of oral cancer symptoms (r = .76, p < .001) reported 
significantly greater support needs. Stage of disease and cancer recurrence were not 
significantly associated with total support needs. Associations between psychosocial 
variables with total support needs suggested that greater cancer-specific distress (r= .85, p < .
001) and higher fears of recurrence (r= .44, p < .001) were significantly associated with 
greater total support needs but impact of cancer was not associated with total support needs. 
The final regression predicting total support needs included income and smoking status in 
the first step, time since diagnosis and oral cancer symptoms in the second step, followed by 
cancer-specific distress and fear of recurrence in the third step. Results are shown in the 
bottom panel of Table 6. Higher total support needs were associated with being a smoker 
and greater cancer-specific distress. The group of variables accounting for 79% of the 
variance in support needs.
Discussion
Although survivors of oral and oropharyngeal cancers typically experience significant long-
term side effects from the cancer itself and its treatment,50 little is known about survivors’ 
post-treatment care experiences and their long-term information and support needs. This 
study sought to characterize survivorship care experiences of a population of patients in the 
state of New Jersey, evaluate information and support needs, and describe background, 
medical, and psychological correlates of these needs.
In our study, oral cancer survivors maintained their post-treatment care provision with the 
treating oncologist, rather than move into the primary care setting for their follow-up care. 
Indeed, like other studies of cancer survivors,51-53 patients considered their cancer specialist 
as their primary physician for cancer-related follow-up care rather than a primary care 
doctor. This finding may be due to the fact that the vast majority of participants experienced 
more than one treatment side effect such as dry mouth, sticky saliva, and dental problems 
which require specialized follow-up care. This may also be due to the frequent post-
treatment surveillance that is recommended and difficult or impossible for a primary care 
provider to perform (e.g., scoping).
Satisfaction with follow-up cancer care provided by the oncologist was extremely high in 
our sample. Despite the current satisfaction with oncology follow-up care, preparation at the 
end of treatment was not ideal. Slightly more than half of our study participants 
retrospectively reported that they did not receive a written summary of the cancer treatments 
they received and details about recommended post-treatment cancer care. The percentage of 
patients reporting that they did not receive a written treatment summary is similar to other 
studies which examined patients with head and neck cancers as well as patients diagnosed 
with other types of malignancies.44,54,55
Furthermore, the majority of the patients who retrospectively reported that they did not 
receive a written summary (or were unsure if they received one) stated that they would have 
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liked to receive one. Almost a quarter of participants reported that a health care professional 
had not discussed possible late and long-term side effects. These findings are consistent with 
prior research with survivors of other types of cancer38 and suggest that oral cancer 
survivors may want more detailed information about their treatment, surveillance protocols, 
and other follow-up recommendations. Information needs were consistent with the fact that 
these survivors had not been provided with written information about recommended follow-
up care. Survivors reported the desire for more information about what late and long-term 
side effects to expect, oral cancer-related follow-up tests recommended, the suspicious 
symptoms that should prompt contacting a doctor, and how to maintain good oral health. 
Each of these topics is a recommended component of the survivorship care plan19,56 which 
is now s a requirement for participating hospitals by the American College of Surgeons’ 
Commission on Cancer.57 Support needs reported in this study were similar to previous 
studies of newly diagnosed oral cancer patients20 and studies of support needs of oral cancer 
survivors.32 These studies have found that health system needs including obtaining test 
results in a timely manner being adequately informed about the benefits and side effects of 
treatments before choosing them, and having a health care provider with whom the patient 
can talk to about all aspects of his/her condition, treatment, and follow-up along with 
physical needs (lack of energy) and daily living needs are the most prevalent needs.20 
Overall, health system and daily living support needs were rated higher than psychosocial 
needs. These results are also consistent with studies of patients who are newly diagnosed 
with other types of cancer58,59 and survivors of other types of cancer.24 Our study differs 
from other studies of newly diagnosed oral cancer patients,20 studies of patients recently 
diagnosed with other types of cancer,60,61 and reviews of support needs of cancer 
survivors58 in that psychosocial concerns (e.g., anxiety, depression, and fear of death and 
dying) were not rated as significant support needs in our study. Unlike prior studies (e.g., 
Zabora et al62) the majority of our sample did not worry about disease progression or 
recurrence or report high levels of cancer–related distress. Low levels of worry about cancer 
progression and distress would lead to low levels of psychological support needs. It is 
interesting to note that, when evaluating the pattern of results across information and support 
needs, information needs were much more prevalent than support needs. A third or more of 
the sample desired more information about oral-cancer specific topics, whereas only one 
domain, a lack of energy, was rated as a moderate or high level support need.
The second goal of our study was to delineate the patient factors that were associated with 
information and support needs. Not surprisingly, our results suggest that two types of 
patients-those who had experienced a recurrence of their cancer and symptoms and those 
who have a greater fear of cancer recurrence-desired more oral cancer information. These 
findings are consistent with previous studies of survivors of other types of cancers showing 
that patients who are more worried about disease recurrence are more likely to actively seek 
information.38 In addition, health behavior theory suggests that persons who worry about 
risk are more likely to seek out information.63 In addition, we found that oral cancer 
survivors who did not currently drink alcohol had significantly higher information needs. 
One possible explanation for this finding is that oral cancer survivors who still drink alcohol 
after an oral cancer diagnosis may be less interested in maintaining or improving their 
health. A post-hoc examination of other differences between survivors who currently drank 
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alcohol and did not drink alcohol suggested that survivors who still drank had higher income 
levels than those who did not, which may account for the finding (although income was not 
significantly associated with information needs). There were no other differences (age, 
ethnicity, education, cancer type, oral cancer symptoms, fear of recurrence, cancer-related 
distress, or impact of cancer) that might explain the finding. Future research may need to 
ascertain why survivors who continue to drink after treatment have fewer information needs 
as well as the underlying risk factors that are associated with income or socioeconomic 
status.
A different set of factors was associated with support needs. After controlling for other 
background and medical factors, we found that current smokers and patients reporting 
greater cancer-specific distress reported higher support needs. Overall, there was a very 
strong association between support needs and greater cancer-specific distress (r = .85) and 
more oral cancer symptoms (r = .75). These strong associations were seen across all four key 
support needs domains, and were not exclusively present in the associations with 
psychological support needs. Although prior research has indicated an association between 
both global psychological distress and cancer-specific distress and unmet support 
needs,25,30,64 the extremely strong association between cancer-specific distress and support 
needs after controlling for relevant background and medical variables suggests that intrusive 
thoughts and feelings and experiential avoidance and experiencing more side effects from 
oral cancer treatment may motivate survivors to desire more support. Current smokers also 
indicated higher support needs, and these differences were noted across all support need 
domains with the exception of sexual issues. One possible explanation for this finding is that 
patients who continue to smoke reported more oral cancer side effects as well as higher 
levels of cancer-related distress. Thus, the higher level of support needs across all domains 
may be explained by smokers’ higher levels of medical side effects and psychological 
distress.
This study has a number of limitations. First, as this is a cross-sectional study, we were not 
able to control for the fact that support needs may change over time21 and are unable to draw 
causal inferences between needs and psychological distress. Second, the sample was 
primarily white, carried medical insurance, and a relatively large proportion were diagnosed 
with stage 4 cancer, which may have biased the sample. Third, the participation rate was not 
high, and the results may be biased towards an unknown characteristic of those who 
participated versus those who did not. Fourth, we did not assess whether the patient's oral 
cancer was HPV-related or not, and we did not assess medical comorbidities. Patients with 
non-HPV-related cancers and patients with more medical comorbidities have been shown to 
have higher information and support needs.9,38 Fifth, the sample was comprised of patients 
with more tongue and tonsil cancers and fewer oropharyngeal cancers than the US 
population and thus may not be representative of the population of these cancers. Sixth, the 
treatment data (e.g., receipt of a care plan, surgery, chemotherapy, and radiation therapy) 
were self-reported. Because participants were diagnosed between two and five years prior, it 
is possible that recollection of treatment facts may be compromised by the passage of time. 
A final limitation is that the measure of alcohol use was global in that participants who 
drank on only one day in the past month were classified as using alcohol. A finer-grained 
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analysis of alcohol consumption would yield more information about the role of alcohol 
consumption on information and support needs.
This study suggests that, following the completion of oral cancer treatment, most patients 
reported that they would like to receive a survivorship care plan, information regarding late 
and long-term side effects, and information about active surveillance for suspicious lesions. 
Our sample of survivors did not report elevated worry about cancer recurrence and distress. 
Oral/oropharyngeal cancer survivors who do not drink alcohol, who continue smoking, 
experience a cancer recurrence, report more fear of recurrence, and experience cancer-
related distress report more needs for either information or health care support. These 
survivor populations may benefit from targeted follow-up services.
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Table 1
Socio-demographic and clinical characteristics of respondents (N=92)
Characteristics No. of patients % Mean (SD) Range
Gender
    Male 68 73.9
    Female 24 26.1
Age 62.1(8.9) 33.4-79.0
Household Income $60,000-74,000 < $20,000->120,000
Ethnicity
    Caucasian/White 81 88.0
    African American /Black 4 4.35
    Hispanic/Latino 4 4.35
    Asian/Pacific Islander 1 1.10
    American Indian 1 1.09
    Missing data 1 1.09
Education Level
    Less than High School 8 8.7
    High School 19 20.6
    Some college/trade school 30 32.6
    College graduate or higher 17 18.4
Marital Status
    Married 61 66.3
    Not married 30 32.6
    Missing data 1 1.1
Employment Status
    Employed 43 46.7
    Homemaker/Caregiver 11 11.9
    Retired 6 6.5
    Not employed 3 3.2
Medical Insurance (yes) 89 93.7
Self-reported primary cancer
    Tongue 43 46.7
    Floor of mouth 6 6.5
    Gum/other area in mouth 8 8.7
    Tonsil 29 31.5
    Oropharynx 6 6.5
Self-reported surgery (yes) 61 66.3
Self-reported location of surgery
    Neck 33 54.1
    Tongue 21 34.4
    Jaw 8 13.1
    Tonsil 9 14.8
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Characteristics No. of patients % Mean (SD) Range
    Floor of mouth/cheek 7 11.5
    Throat 9 14.8
    Nodal dissection 8 13.1
Self-reported chemotherapy (yes) 60 65.2
Self-reported radiation (yes) 77 83.7
Self-reported cancer recurrence (yes) 7 7.6
Self-reported month since diagnosis 41.3 (6.4) 23.1-70.0
Disease stage
    1 12 13.0
    2 8 8.7
    3 14 15.2
    4 49 53.3
    Unknown 9 9.8
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Table 2
Post-Treatment Oral Cancer Care Experiences
Variable No. of patients (%)
Was informed by physician about the need for follow-up care 88 (95.7)
Was a reason provided for follow-up care
*
    Did not discuss a reason 8 (9.1)
    Yes, discussed somewhat 17 (19.3)
    Yes, discussed in detail 62 (70.4)
    Missing data 1 (1.1)
Reason for follow-up care provided
*
    Check for recurrence 79 (98.3)
    Additional treatment 1 (1.2)
    Determine if have health problems as a result of cancer treatment 1 (1.2)
    To receive tests or exams for non-cancer diseases such as heart disease, hypertension, or diabetes 1 (1.2)
Patient-reported most important reason for follow-up care
*
    Check for recurrence 67 (76.1)
    Additional treatment for cancer if needed 4 (4.5)
    Determine if have health problems as a result of cancer treatment 3 (3.4)
    Treatment for any symptoms or side effects of treatment 1 (1.1)
    Routine physical exam 2 (2.3)
    Screening for other types of cancer 1 (1.1)
    Missing data 11 (12.5)
Physician/HCP discussed late and long-term side effects of oral cancer treatment
    No, did not discuss 20 (21.7)
    Yes, discussed somewhat 27 (29.3)
    Yes, discussed in detail 44 (47.8)
    Missing data 1 (1.1)
Written treatment summary about cancer care provided
    Yes 32 (34.8)
    No 48 (52.2)
    Unsure 10 (10.9)
If you received a summary, summary can be located
*
    Yes 15 (16.3)
    No 4 (4.3)
    Unsure 13 (14.1)
Would have liked to receive a written treatment summary
    Yes 46 (17.4)
    No 16 (50.0)
    Unsure 9 (14.1)
Has seen a HCP for oral cancer-related follow-up care since diagnosis 86 (93.5)
Type of HCP was seen for follow-up care (more than one choice)
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Variable No. of patients (%)
    Cancer specialist 70 (65.4)
    PCP 18 (16.8)
    Dentist 1 (.9)
    Plastic surgeon 1 (.9)
    Cardiologist 1 (.9)
    Ear, Nose, and Throat Specialist 16 (14.8)
Has a HCP considered the primary provider of follow-up care 83 (90.2)
HCP that is considered primary provider of follow-up care
    Cancer specialist 62 (74.6)
    PCP 7 (8.4)
    Ear, Nose, and Throat Specialist 11 (13.2)
    Dentist 2 (2.4)
Oral cancer-related follow-up care provided was helpful
    Always 35 (40.6)
    Usually 10 (11.6)
    Sometimes 6 (7.0)
    Never 2 (2.3)
    Missing data 33 (38.4)
Quality of oral cancer-related follow-up care
    Excellent 57 (62)
    Very Good 23 (25)
    Good 8 (8.7)
    Fair 0 (0)
    Poor 1 (1.1)
    Missing 3 (3.3)
Note: HCP = Health care provider
*
Denominator reflects the number of persons who answered yes to the relevant item
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Table 3
Descriptive information regarding oral cancer-related information needs
Information Needs No. of patients %
What late and long-term side effects of oral cancer treatment to expect 53 58.9
Oral cancer follow-up tests that you should have 52 58.4
Oral cancer symptoms that should prompt you to call your doctor 52 57.7
Maintaining good nutrition and diet given issues with eating 37 41.1
Improving your speech or swallowing issues 31 34.4
Getting or maintaining health, life or disability insurance after cancer 30 33.3
Maintaining good oral health 30 33.3
Managing anxiety about recurrence of your cancer 28 31.5
Dealing with changes in my facial appearance due to survey/radiation 22 24.4
Dealing with social life such as eating public 18 20.2
Dealing with the effects of oral cancer on your marital or dating life 17 18.9
Note: The percentage refers to the percentage of patients endorsing “yes” and Ns varied between 89 and 90.
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Table 4
Descriptive information regarding support needs
Support Needs Percent of Sample Moderate 
or High Need
Physical and Daily living
    Pain 12.1
    Lack of energy 25.0
    Feeling unwell 13.1
    Work around home 12.1
    Not being able to do things 20.9
Psychological
    Anxiety 17.6
    Feeling down or depressed 13.4
    Fear of cancer spreading 18.5
    Uncertainty about future 13.2
    Keeping a positive outlook 12.0
    Feelings about death and dying 10.8
Health Systems and Information
    Being given written information about care 13.2
    Being given information about aspects of managing your illness and side effects at home 13.2
    Being adequately informed about the benefits and side effects of treatment before you choose to have them 23.4
    Being informed about your test results as soon as feasible 24.2
    Having access to professional counseling should you need it 15.4
    Being given explanations for tests that you would like explained 15.4
    Being informed about things you can do to help yourself 19.8
    Being treated in a health care clinic that is physically pleasant 14.6
    Having a HCP with whom you can talk to about all aspects of your condition, treatment and follow up 23.1
Patient Care and Support
    More choice about which cancer specialist to see 4.4
    Reassurance by HCP that feelings are normal 12.1
    HCP attending promptly to physical needs 9.9
    HCP to acknowledge and show sensitivity 13.2
Sexuality
    Changes in your sexual relationship 18.0
Note: HCP = Health care provider
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Table 5
Descriptive information on oral cancer symptoms, fear of cancer recurrence, cancer-related distress
Variable Mean (SD) No. of patients (%) Range
Oral cancer symptoms
    Average pain item score 1.66 (.6) 1-4
    Pain 1.60 (.7) 1-4
    Swallowing 1.62 (.7) 1-4
    Senses 1.78 (.8) 1-4
    Speech 1.50 (.7) 1-4
    Social Eating 1.70 (1.0) 1-4
    Social Contact 1.34 (.6) 1-4
    Sexuality 1.60 (1.0) 1-4
    Teeth 2.13 (1.3) 1-4
    Opening mouth 1.83 (1.1) 1-4
    Dry mouth 2.70 (1.1) 1-4
    Sticky saliva 2.40 (1.2) 1-4
    Coughing 1.27 (.65) 1-4
    Take pain killers 30 (32.6) 1-2
    Take nutritional supplement 37 (40.2) 1-2
    Use feeding tube 4 (4.3) 1-2
    Lost weight 14 (15.2) 1-2
    Gained weight 20 (21.7) 1-2
Impact of Cancer 34.67 (15.9) 0-85
Fear of recurrence 2.50 (1.4) 1-6
Cancer-specific distress 12.47 (18.0) 0-86
Note: For the impact of cancer and fear of recurrence scales, the mean item rating was calculated.
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